Video

Dr. Arora on the Evolution of Treatment in Follicular Lymphoma

Madan L. Arora, MD, discusses the evolution of treatment in follicular lymphoma.

Madan L. Arora, MD, clinical associate professor, medicine, Michigan State University, College of Human Medicine, discusses the evolution of treatment in follicular lymphoma.

Significant progress has been made in the treatment landscape for patients with follicular lymphoma, with the addition of several new agents, Arora says. This multitude of available options has improved the overall survival of patients, Arora adds.

Patients are now able to receive a fixed duration of therapy that has led to prolonged survival for a majority of patients while maintaining a reasonable quality of life, Arora concludes.

Related Videos
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Tracy George, MD
Elias Jabbour, MD
Bently P. Doonan, MD
Eytan M. Stein, MD
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center